1. Home
  2. ULCC vs WVE Comparison

ULCC vs WVE Comparison

Compare ULCC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULCC
  • WVE
  • Stock Information
  • Founded
  • ULCC 1994
  • WVE 2012
  • Country
  • ULCC United States
  • WVE Singapore
  • Employees
  • ULCC N/A
  • WVE N/A
  • Industry
  • ULCC Air Freight/Delivery Services
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULCC Consumer Discretionary
  • WVE Health Care
  • Exchange
  • ULCC Nasdaq
  • WVE Nasdaq
  • Market Cap
  • ULCC 1.1B
  • WVE 915.6M
  • IPO Year
  • ULCC 2021
  • WVE 2015
  • Fundamental
  • Price
  • ULCC $3.60
  • WVE $8.31
  • Analyst Decision
  • ULCC Hold
  • WVE Strong Buy
  • Analyst Count
  • ULCC 9
  • WVE 14
  • Target Price
  • ULCC $5.63
  • WVE $20.79
  • AVG Volume (30 Days)
  • ULCC 3.8M
  • WVE 3.6M
  • Earning Date
  • ULCC 11-05-2025
  • WVE 11-07-2025
  • Dividend Yield
  • ULCC N/A
  • WVE N/A
  • EPS Growth
  • ULCC N/A
  • WVE N/A
  • EPS
  • ULCC N/A
  • WVE N/A
  • Revenue
  • ULCC $3,778,000,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • ULCC $1.14
  • WVE N/A
  • Revenue Next Year
  • ULCC $13.33
  • WVE $6.26
  • P/E Ratio
  • ULCC N/A
  • WVE N/A
  • Revenue Growth
  • ULCC 4.60
  • WVE N/A
  • 52 Week Low
  • ULCC $2.89
  • WVE $5.28
  • 52 Week High
  • ULCC $10.26
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • ULCC 37.74
  • WVE 56.37
  • Support Level
  • ULCC $4.11
  • WVE $8.18
  • Resistance Level
  • ULCC $3.88
  • WVE $9.75
  • Average True Range (ATR)
  • ULCC 0.25
  • WVE 0.64
  • MACD
  • ULCC -0.04
  • WVE 0.14
  • Stochastic Oscillator
  • ULCC 11.93
  • WVE 48.94

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: